What Parents Should Know About Neurofeedback for ADHD

On Thursday, April 20th, at 1 pm ET, join us for a free expert webinar with David Rabiner, Ph.D., and Ed Hamlin, Ph.D.
ADDitude Webinars | posted by ADDitude Editors

Register for this free webinar here.

Not available April 20th? Don't worry. As long as you register, we'll send you the replay link to watch at your convenience.

Neurofeedback — also known as EEG biofeedback — gives real-time feedback on brainwave activity to individuals with ADHD who are taught to achieve EEG patterns consistent with focus and attention. Neurofeedback proponents say it results in improved attention and reduced hyperactive/impulsive behavior. Researchers began studying neurofeedback in the 1970s and have published a number of supportive studies, however many experts say the efficacy of neurofeedback for ADHD remains unclear. Many parents are uncertain whether to pursue this treatment regimen for their children.

This webinar will explain neurofeedback and touch on the following topics:
> How long neurofeedback has been used to treat ADHD, and the theoretical basis for it

> The basics of neurofeedback treatment, including its costs and typical duration

> The results parents should expect to see in children with ADHD

> Whether neurofeedback should be used alone or in combination with medication and/or behavior therapy

> The research supporting neurofeedback as a treatment for ADHD

> Home-based neurofeedback systems and important considerations for trying them

About the Expert Speakers

David Rabiner, Ph.D., currently serves as a senior associate dean and a research professor in the department of psychology and neuroscience. Dr. Rabiner has published over 50 peer-reviewed papers on children's social development, the impact of attention difficulties on academic achievement, computer-based interventions for attention problems, helping community practitioners provide better evaluation and treatment to children with ADHD, and the nonmedical use of ADHD medications by college students. Dr. Rabiner publishes an online newsletter called Attention Research Update that helps over 30,000 subscribers stay informed about important new research on ADHD. Free subscriptions are available at www.helpforadd.com. He is also the co-developer of Nervanix Insight, a new attention training system that you can learn about on YouTube.

Ed Hamlin, Ph.D., is the founder and clinical director of the Institute for Applied Neuroscience in Asheville, North Carolina, where he specializes in the application of neuroscience techniques to address a range of difficulties, including attention problems. Dr. Hamlin received his Ph.D. in clinical psychology from UNC-Chapel Hill and taught at UNC and Duke before returning to Asheville. Dr. Hamlin specializes in applied neuroscience techniques to help address attention problems, cognitive disorders, depression, anxiety, and problems associated with traumatic and acquired brain injuries. He is the lead instructor for EEG Education and Research and is on the faculty for Evidence-Based Neurotherapy of the Society for the Advancement of Brain Analysis. Dr. Hamlin is a recognized leader in the neurofeedback field and has trained thousands of clinicians to use neurofeedback. He is also a co-developer of Nervanix Insight.

The sponsor of this week's ADDitude webinar is....
Play Attention: Play Attention is the only brain training system that combines both advanced neurofeedback and cognitive training to effectively improve attention, behavior, and learning skills in children and adults with ADHD. www.playattention.com.

ADDitude webinar sponsors have no role in the selection of guest speakers, the speaker's presentation, or any other aspect of the webinar production.
"ADHD 101: Practical Advice and Real-Life Stories"
  • How to recognize and diagnose symptoms in adults and kids
  • How to find an ADHD expert
  • What to expect from popular ADHD medications
  • How alternative therapies can supplement your treatment plan

Copyright © 1998 - 2016 New Hope Media LLC. All rights reserved. Your use of this site is governed by our Terms of Service and Privacy Policy.
ADDitude does not provide medical advice, diagnosis, or treatment. The material on this web site is provided for educational purposes only. See additional information.
New Hope Media, 108 West 39th Street, Suite 805, New York, NY 10018